When mild cognitive impairment cut trial attorney Dale Rivard’s career in law short, he started a fulfilling new chapter. For Dale Rivard, practicing law…
Longeveron’s investigational early-stage Alzheimer’s drug Lomecel-B, made from donated bone marrow, is enrolling participants for a clinical trial. Scientists have faced obstacle after obstacle…
A Phase 2a clinical trial is underway to test the possible benefits of sodium selenate for people living with frontotemporal dementia. While Alzheimer’s is…
Salk Institute Neurobiologist Zhibin Liang discusses the neuroprotective effects of a cannabis compound known as cannabinol, and the road ahead to validate and build…
A new study finds a possible link between foods with inflammatory properties and smaller brain volume — a marker for brain aging. Experts emphasize…
A new study shows that people who have green space, like parks, near their homes are reaping cognitive health benefits. When it comes to…
New research sheds light on the inspiring displays of strength and optimism that can follow a Parkinson’s diagnosis. In a Q&A, Neurologist Bastiaan Bloem…